OTCQB: PHRRF | CSE: PHRM
PharmaTher Holdings Ltd. Ketamine
  • HOME
  • COMPANY
  • PORTFOLIO
    • MEDBOTX
    • KETAMINE
    • Psychedelics
    • CEPHARANTHINE
  • INVESTORS
  • NEWS
  • HOME
  • COMPANY
  • PORTFOLIO
    • MEDBOTX
    • KETAMINE
    • Psychedelics
    • CEPHARANTHINE
  • INVESTORS
  • NEWS

Psychedelics Patch

​PharmaPATCH™

PharmaPATCH™: Proprietary Microneedle Delivery Platform
PharmaPATCH™ is a proprietary microneedle-enhanced delivery system designed to provide an efficient, minimally invasive, and potentially painless method for delivering drug candidates, including psychedelics, peptides, and other medicines. 
Picture
​​PharmaPATCH™ is also intended to support at-home self-administration and incorporates anti-tampering and anti-abuse features. The Company has completed research studies demonstrating PharmaPATCH™ feasibility for delivering psychedelic compounds, including ketamine, DMT, psilocybin, MDMA, and LSD.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."
The proposed PharmaPatch™ products are strictly for research use only and are not intended for human cosmetic or therapeutic applications at this time.

Connect With Us

Picture
Picture
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario  Canada
M5C 1P1
Psychedelic Pharmaceuticals
Contact Us
© COPYRIGHT 2026.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."